peptide (Aβ) in the brain, one of the pathological features of AD, is considered to be a central disease-causing and diseasepromoting event in AD. in this study, we show that feeding male APP/PS1 transgenic mice, a well-established mouse model of AD, with a diet containing phenolic antioxidant tertbutylhydroquinone (TBHQ) for 6 weeks increased the concentration of glutathione (GSH), an important antioxidant, and suppressed the expression of NADPH oxidase 2 (Nox2) as well as lipid peroxidation in the brain. Most importantly, we show that TBHQ diet dramatically reduced brain Aβ load, which was associated with inhibition of the expression of plasminogen activator inhibitor-1 (PAI-1), a redox sensitive protease inhibitor which plays a critical role in brain Aβ accumulation in AD. This was accompanied by increases in the activities of tissue type and urokinase type plasminogen activators (tPA and uPA) as well as plasmin. Moreover, we show that TBHQ diet increased the expression of low density lipoprotein related protein-1 (LRP-1), a multi ligand endocytotic receptor involved in transporting Aβ out of the brain, and plasma Aβ40 and Aβ42 levels. No significant effect of TBHQ diet on the amounts of alpha-and beta-C-terminal fragments or full-length APP was detected. Collectively, our data suggest that TBHQ may have therapeutic potential for AD through increasing brain antioxidant capacity/reducing oxidative stress level, which leads to inhibition of PAI-1 expression and thereby stimulation of Aβ degradation/clearance from the brain. Northwestern University As an important environmental carcinogen, UVR not only generates ROS, but also produces a large amount of nitric oxide (NO) in human skin. Utilizing a NO-donor (DETA) to mimic NO stress, we demonstrated that melanoma proliferation and invasion potential were significantly stimulated. Notably, long-term exposure of DETA/NO stress resulted in over-growth of primary normal human melanocytes with formation of foci in vitro. NO is predominantly generated in an enzyme-dependent manner via NO synthase (NOS). As melanocytes originate from the neural crest, we propose that neural NOS (nNOS) might play an important role in NO production in melanoma. Immunohistochemistry study using biopsies demonstrated marked elevation of nNOS expressions in melanoma and further trend analysis revealed that the staining scores of lesions are significantly associated with disease stage. More progressive stage samples exhibited higher nNOS levels. Significant
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inductions of nNOS and elevated NO levels were evident after UVA or UVB radiation. Knockdown of nNOS with siRNA efficiently inhibited melanoma invasion potential, with marked reductions of c-Jun, Bcl-2 and MMP-1. Co-treatment of JI-11, a nNOS inhibitor, efficiently diminished the overgrowth of melanoma stimulated by L-arginine in 3-dimersional skin reconstructs. Additionally, a series of novel synthesized nNOS inhibitors were also tested, which represented a varied range of structures and distinct potentials and enzyme selectivity. the nNOS inhibitory potencies (represented by K i /nNOS values) were correlated with their observed anti-melanoma activities, but not K i/ iNOS or K i /eNOS, indicating that the inhibition of nNOS is crucial for reducing melanoma invasion. in toto, targeting nNOS with application of specific synthetic inhibitors to diminish NO stress represents an innovative and promising strategy for melanoma prevention and therapy. University of Tsukuba, 2 MANA, NIMS Utilizing the self-assembled core-shell-type polymeric micelle technique, high-performance nanoparticles possessing stable nitroxide radicals in the core and reactive groups on the periphery were prepared (Nitroxide Radical-containing Nanoparticles; RNP). the average diameter of the nanoparticles was ca. 40 nm, and the nanoparticles emitted intense electron paramagnetic resonance (EPR) signals. Owing to the confinement of the nitroxide groups in the core of the nanoparticles, it reduces tis toxicity, prolongs its blood circulation time. Under the low pH environment in vivo, it was confirmed that RNP disintegrated to expose the nitroxide radicals outside of the particle. It is sharp contrast against low-molecular-weight TEMPOL, which was reduced and excreted rapidly from the blood stream. Recently, we have reported that RNP is effective to cerebral ischemia reperfusion injury. the RNP disintegrates in penumbra area due to the acidosis of ischemic region, followed by the scavenging reactive oxygen species (ROS) generated in this area. This strategy could be applied to other ischemic injuries such as renal and myocardial infarction. Quite recently, we have found that scavenging of ROS in tumor region by RNP improves efficiency of anticancer drug, doxorubicin (DOX).
for example, RNP administration prior to the DOX-injection remarkably improved its efficiency. the RNP pre-administration also reduced its side effect. Actually, 25mg/kg intravenous administrations of RNP before and after the DOX-injection (20mg/kg) reduced significantly the lactate dehydrogenase (LDH) and the creatine kinase (CK) activity. Thus, the nanoparticle anti-oxidant treatment is promising as a new adjuvant for anti-cancer chemotherapy without severe side effect by anticancer drug. University of Tsukuba, 2 MANA, NIMS We have newly developed nitroxide-radical containing nanoparticle (RNP), which is constructed by amphiphilic block copolymer possessing stable 2,2,6,6-tetramethylpiperidinyl-1-oxyl (TEMPO) moiety as a side chain of hydrophobic segment. Confinement of the nitroxide radicals in the core of the nanoparticle decreased its toxicity and rapid metabolism to improve blood circulation tendency. Because the nitroxide radical scavenges reactive oxygen species (ROS), we have investigated an antioxidative efficiency of RNP for cerebral, renal and cardiovascular ischemia-reperfusion injyuries, intracerebral hemorrhage, Alzheimer's disease, cancer chemotherapy and gene delivery system so far and confirmed its high effect. in this study, we have applied this nanoparticle for oral nanotherapy. RNP was orally administered to ulcerative colitis model rats prepared by dextran sodium sulphate (DSS). Using fluorescent imaging and electron spin resonance (ESR) analyses, it is confirmed that accumulation of nitroxide radicals in mucosa membrane in colon increased more than two orders of magnitude as compared to low-molecular-weight TEMPO compounds. Especially, it is much increased in injured colon mucosa than that in normal colon mucosa. Although RNP is accumulated in the mucosa membrane, no uptake in blood stream was observed, whish is ideal character because of avoidance of side effect in whole body. Kagawa University, Japan Loss of filaggrin causes a poorly formed stratum corneum, and subsequently elicits disruption of skin barrier function that leads to enhanced percutaneous transfer of allergens with the incidence of atopic dermatitis. Flaky tail mice are filaggrin deficient mice in nature and have been used to investigate the role of filaggrin in skin patho/physiology. However, the mechanism remains unclear why loss of filaggrin causes skin barrier dysfunction. Epidermal growth factor receptor (EGFR), E-cadherin, occludin and SIRT1 are skin barrier-related proteins. We found that these skin barrierrelated proteins are decreased in the skin of 8 week old flaky tail mice. of note, N-acetyl-L-cysteine (NAC) supplement increased these skin barrier-related protein expressions, implying the involvement of oxidative stress. Aging are known to accompany the increased levels of oxidative stress in various tissue including skin. the reduced expression of these protein expressions was not observed in 8 week old C57BL/6J control mice but observed in 32 week old C57BL/6J control mice. Our findings suggest that NAC may be considered as a future therapeutic agent in the treatments of atopic dermatitis that strengthens the skin barrier function.
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